Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Environ Pollut ; 269: 116101, 2021 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-33307395

RESUMO

Microbial biosurfactants are surface-active molecules that are naturally produced by a range of microorganisms. They have certain advantages over chemical surfactants, such as lower toxicity, higher biodegradability, anti-tumor, and anti-microbial properties. Sophorolipids (SLs) in particular are one of the most promising biosurfactants, as they hold the largest share of the biosurfactant market. Currently, researchers are developing novel approaches for SL production that utilize renewable feedstocks and advanced separation technologies. However, challenges still exist regarding consumption of materials, enzymes, and electricity, that are primarily fossil based. Researchers lack a clear understanding of the associated environmental impacts. It is imperative to quantify and optimize the environmental impacts associated with this emerging technology very early in its design phase to guide a sustainable scale-up. It is necessary to take a collaborative perspective, wherein life cycle assessment (LCA) experts work with experimentalists, to quantify environmental impacts and provide recommendations for improvements in the novel waste-derived SL production pathways. Studies that have analyzed the environmental sustainability of microbial biosurfactant production are very scarce in literature. Hence, in this work, we explore the possibility of applying LCA to evaluate the environmental sustainability of SL production. A dynamic LCA (dLCA) framework that quantifies the environmental impacts of a process in an iterative manner, is proposed and applied to evaluate SL production. The first traversal of the dLCA was associated with the selection of an optimal feedstock, and results identified food waste as a promising feedstock. The second traversal compared fermentation coupled with alternative separation techniques, and highlighted that the fed-batch fermentation of food waste integrated with the in-situ separation technique resulted in less environmental impacts. These results will guide experimentalists to further optimize those processes, and improve the environmental sustainability of SL production. Resultant datasets can be iteratively used in subsequent traversals to account for technological changes and mitigate the corresponding impacts before scaling up.


Assuntos
Alimentos , Eliminação de Resíduos , Animais , Estágios do Ciclo de Vida , Ácidos Oleicos , Tecnologia
2.
PLoS One ; 11(6): e0156845, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27271048

RESUMO

Sophorolipids (SL) are amphiphilic biosurfactant molecules consisting of a disaccharide sophorose with one fatty acid at the C1 position and optional acetylation at the C6'and C6" positions. They exist in a closed ring lactonic (LSL) or open acidic (ASL) structure Sophorolipids are produced in crude mixtures in economically viable amounts by the yeast Starmerella bombicola and used in a variety of consumer products. Varying levels of anti- proliferative and anti-cancer activity of crude sophorolipid mixtures are described in a number of tumor cell lines in vitro. However, significant inter-study variation exists in the composition of sophorolipid species as well as other biologically active compounds in these mixtures, which makes interpretation of in vitro and in vivo studies difficult. We produced a 96% pure C18:1 lactonic sophorolipid that dose-dependently reduces the viability of colorectal cancer, as well as normal human colonic and lung cell lines in vitro. Oral administration of vehicle-only; or lactonic sophorolipids (50 mg/kg for 70 days), to Apcmin+/- mice resulted in an increase in the number (55.5 ± 3.3 vs 70.50 ± 7.8: p < 0.05) and size (modal size 2mm vs 4mm) of intestinal polyps. Lactonic administration resulted in a systematic effect via reduced hematocrit (49.5 ± 1.0 vs 28.2 ± 2.0 vs: p<0.03) and splenomegaly (0.56 ± 0.03g vs 0.71 ± 0.04g; p<0.01) confirming exacerbation of disease progression in this model.


Assuntos
Neoplasias Colorretais/patologia , Glicolipídeos/farmacologia , Carga Tumoral/efeitos dos fármacos , Animais , Ascomicetos/química , Células CACO-2 , Extratos Celulares/isolamento & purificação , Extratos Celulares/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Neoplasias Colorretais/genética , Feminino , Genes APC , Células HCT116 , Células HT29 , Humanos , Masculino , Camundongos , Camundongos Transgênicos , Regulação para Cima/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA